Page last updated: 2024-09-03

2-ethylidene-1,5-dimethyl-3,3-diphenylpyrrolidine and Complications, Pregnancy

2-ethylidene-1,5-dimethyl-3,3-diphenylpyrrolidine has been researched along with Complications, Pregnancy in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
de Castro, A; Gray, TR; Huestis, MA; Johnson, RE; Jones, HE; Shakleya, DM2

Trials

2 trial(s) available for 2-ethylidene-1,5-dimethyl-3,3-diphenylpyrrolidine and Complications, Pregnancy

ArticleYear
Maternal methadone dose, placental methadone concentrations, and neonatal outcomes.
    Clinical chemistry, 2011, Volume: 57, Issue:3

    Topics: Analgesics, Opioid; Apgar Score; Birth Weight; Body Size; Cephalometry; Cocaine; Female; Gestational Age; Humans; Infant, Newborn; Maternal Exposure; Meconium; Methadone; Opiate Substitution Treatment; Opioid-Related Disorders; Placenta; Pregnancy; Pregnancy Complications; Pregnancy Outcome; Pregnancy Trimesters; Pyrrolidines; Tissue Distribution

2011
Methadone, cocaine, opiates, and metabolite disposition in umbilical cord and correlations to maternal methadone dose and neonatal outcomes.
    Therapeutic drug monitoring, 2011, Volume: 33, Issue:4

    Topics: Adult; Analgesics, Opioid; Buprenorphine; Cocaine; Dose-Response Relationship, Drug; Female; Humans; Infant, Newborn; Maternal-Fetal Exchange; Meconium; Methadone; Narcotics; Neonatal Abstinence Syndrome; Opioid-Related Disorders; Placenta; Pregnancy; Pregnancy Complications; Pregnancy Outcome; Pyrrolidines; Umbilical Cord

2011